EASTERN COOPERATIVE ONCOLOGY GROUP

这项拨款的主要目的是确保资金支持范德比尔特大学医学院东部肿瘤合作小组（ECOG）的临床研究活动，促进ECOG试验的患者累积，扩大对ECOG赞助的临床试验和实验室研究的科学和行政贡献，2)进一步增加范德比尔特大学研究人员对ECOG的科学和行政贡献。3)继续发展常见实体肿瘤和血液系统恶性肿瘤的创新治疗方案，4)保持高水平的数据质量和管理，这是该机构所知的。这些目标将通过来自医学肿瘤学、放射肿瘤学、病理学和外科科学部门的研究人员的密切互动来实现。范德比尔特的调查和其他ECOG机构之间的互动将由范德比尔特的研究人员在许多ECOG疾病导向委员会和模式委员会的存在促进。范德比尔特癌症中心拥有成功执行合作小组临床试验的所有必要因素，包括优秀的数据管理人员，优秀的门诊和住院设施，这项工作将在其中进行，以及合作小组参与的悠久历史。

The principle objectives of this grant are to secure funding to support the clinical research activity of the Eastern Cooperative Oncology Group (ECOG) at Vanderbilt University Medical School, to facilital patient accrual to ECOG trials, and to expand the scientific and administrative contributions made to ECOG sponsored clinical trials and laboratory studies, 2) to further increase the scientific and administrative contributions to ECOG by Vanderbilt investigators, 3) to continue the development of innovative treatment programs for common solid tumors and hematologic malignancies, and 4) to maintain a high level of data quality and management for which the institution is known. These goals will be achieved through the close interaction of investigators from medical oncology, radiation oncology, pathology and the section of surgical sciences. The interactions between Vanderbilt investigations and other ECOG institutions will be facilitated by the presence of Vanderbilt investigators on numerous ECOG disease oriented committees and modality committees. The Vanderbilt Cancer Center has in place all the necessary elements for the successful execution of cooperative group clinical trials including an outstanding data management staff, excellent outpatient and inpatient facilities in which this work will be undertaken and a long history of cooperative group participation.